CSSSI

(redirected from Complicated Skin and Skin Structure Infections)
AcronymDefinition
CSSSIComplicated Skin and Skin Structure Infections
References in periodicals archive ?
This report provides comprehensive information on the therapeutic development for Complicated Skin And Skin Structure Infections (cSSSI), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
The researchers analyzed data from the Assessment of Telavancin in Complicated Skin and Skin Structure Infections (ATLAS) trials, which were identical randomized, double-blind trials conducted among 1,867 adults with complicated SSSIs due to suspected or confirmed gram-positive pathogens (Clin.
The FDA granted ceftobiprole fast-track designation for the treatment of complicated skin and skin structure infections due to methicillin-resistant Staphylococcus species and for a second indication in the treatment of hospital-acquired (nosocomial) pneumonia, including ventilator-associated pneumonia due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
A snapshot of the global therapeutic scenario for Complicated Skin And Skin Structure Infections (cSSSI).
The drug is approved for treatment of complicated skin and skin structure infections caused by susceptible strains of gram-positive organisms.
Ceftaroline monotherapy was as effective and well tolerated as vancomycin plus aztreonam combination therapy in treating patients with complicated skin and skin structure infections due to both gram-positive and gram-negative pathogens," reported Dr.
Approval was based on studies in more than 1,400 adults showing that Cubicin was equal to standard treatments, such as vancomycin, or a semisynthetic penicillin such as oxacillin or nafcillin, in treating complicated skin and skin structure infections, the FDA said in a statement.
The report, Hospital Insight Series: Complicated Skin and Skin Structure Infections (Europe), uses clinical audit data and primary research with infectious disease specialists to understand the dynamics of product usage and physicians' treatment patterns.
Dalbavancin could be an alternative to vancomycin and linezolid for complicated skin and skin structure infections caused by gram-positive pathogens, and since it can be administered in outpatient settings, it might be a reasonable option for empirical treatment of such infections suspected to be caused by MRSA, the investigators said.
The Food and Drug Administration has expanded the indications for Levaquin to include complicated skin and skin structure infections, such as major abscesses; ulcers; and infections of deep.
Complicated Skin and Skin Structure Infections - An oral, bactericidal antibiotic with activity against methicillin-resistant Staphylococcus aureus (MRSA) for the treatment of complicated skin and skin structure infections
Daptomycin is approved for the treatment of complicated skin and skin structure infections that are caused by susceptible strains of gram-positive organisms.